2023³â ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦27Â÷ Ãß°èÇмú´ëȸ : 2023-10-28
±³À°ÀÏÀÚ : 2023-10-28
±³À°Àå¼Ò : ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ : 2023³â ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦27Â÷ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ
´ã´çÀÚ : ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-2291-2290
À̸ÞÀÏ : kscn@kscn.or.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í ȸ¿ø: Çмú´ëȸ-3¸¸¿ø(Àü°øÀÇ ¹× ±â»ç)/5¸¸¿ø(Àü¹®ÀÇ), ºñȸ¿ø: Çмú´ëȸ-4¸¸¿ø(Àü°øÀÇ ¹× ±â»ç)/6¸¸¿ø(Àü¹®ÀÇ)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:00~09:30 Vasovagal syncope À±º°¾Æ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:30~10:00 Intraoperative neurophysiologic monitoring ±Ç¿µ³²(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:00~10:30 Polysomnography ÀÓÈñÁø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:40~11:05 MR neurography ±èÇö¼ö(¼º±Õ°üÀÇ´ë, ¿µ»óÀÇÇаú)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:05~11:30 Muscle MRI À±¿µÃ¶(¼º±Õ°üÀÇ´ë, ¿µ»óÀÇÇаú)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:30~11:55 Functional neuroimaging of vestibular stimulation ÀÌÀͼº(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:55~12:20 Inner ear structural imagings in vestibular diseases ¿À¼±¿µ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:30~13:30 Advances in Neuromuscular Ultrasound and Relevance to Electrophysiology Michael Stephen Cartwright(Wake Forest University)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:40~14:10 Revisiting Parkinson's Disease: Unraveling the Brain-First and Body-First Perspectives ÀÌ¿õ¿ì(À»ÁöÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:10~14:40 Multimodal MRI approach in Parkinsonian Disorders ¼º¿µÈñ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:40~15:10 Insights into Nuclear Medicine Applications for Parkinsonian Disorders ÃÖÈ«À±(¼¿ïÀÇ´ë, ÇÙÀÇÇаú)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:20~15:50 Preclinical Alzheimer's disease and subjective cognitive decline in clinical settings È«À±Á¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:20 Diagnostics in Alzheimer's disease: beyond neuroimaging ÆíÁ¤¹Î(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10¿ù 28ÀÏ ¼¿ï »ï¼º»ý¸íºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:20~16:50 Anti-Amyloid treatment in Alzheimer's disease : clinical and neuroimaging biomarker outcomes °¹ÎÁÖ(Áß¾Óº¸Èƺ´¿ø)